1-818-812-7222 Office Hours: Monday Thru Friday: By Appointment only
Article Category: COVID-19
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
Date of Publication: March 2020
Pathogenicity and transmissibility of 2019-nCoVdA quick overview and comparison with other emerging viruses
Coronaviruses are a group of viruses that cause a significant percentage of all common colds in human adults and children. Four human coronavirus including 229E, OC43, NL63, and HKU1 are prevalent and typically cause common cold symptoms in immu- nocompetent individuals.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Date of Publication: February 2020
This publication presents epidemiological, clinical, laboratory, and radiological characteristics, treatment, and outcomes of patients confirmed to have 2019-nCoV infection. It aims to compare the clinical features between intensive care unit (ICU) and non-ICU patients. As a result of the data presented the publishers also make clinical recomendation.
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Date of Publication: February 2020
Coronavirus is at the root of this global pandemic. The research and pharmaceutical scientist are rushing to identify, test and manufacture agains this virus. However; there are possible medications currently available that may prove to be effective against this virus at some level. There are group of scientists who are looking at the existing arsenal of medications.
New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
See the recent article published in 2019 about a novel medication for Rheumatoid Arthritis (RA) Baricitinib.

Recent Posts
- Cholangitis May 24, 2026
- Bile Reflux Gastritis May 19, 2026
- Sphincter of Oddi Dysfunction April 26, 2026
- Types of HyperParathyroidism February 20, 2026
- Vitamin D level and Liver Function Test (LFT) elevation February 8, 2026

